Tianyin Pharmaceutical Co Stock Current Liabilities
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Current Liabilities Analysis
Tianyin Pharmaceutical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Tianyin Pharmaceutical Current Liabilities | 4.15 M |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Tianyin Pharmaceutical Co has a Current Liabilities of 4.15 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The current liabilities for all United States stocks is notably lower than that of the firm.
Tianyin Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in current liabilities category among its peers.
Tianyin Fundamentals
| Return On Asset | -1.24 | |||
| Profit Margin | (13.72) % | |||
| Operating Margin | (7.06) % | |||
| Current Valuation | (7.22 M) | |||
| Shares Outstanding | 29.43 M | |||
| Shares Owned By Insiders | 26.44 % | |||
| Shares Owned By Institutions | 6.40 % | |||
| Number Of Shares Shorted | 112.52 K | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 0.05 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 29.64 M | |||
| Gross Profit | 15.88 M | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 15.16 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.64 X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 1 K | |||
| Beta | 2.79 | |||
| Total Asset | 101.35 M | |||
| Retained Earnings | 50.19 M | |||
| Working Capital | 23.39 M | |||
| Current Asset | 27.53 M | |||
| Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |